Sentences with phrase «report filed this year»

Mr. Cuomo said he was dumbfounded by Mr. Rattner's unwillingness to end the dispute with a payment that amounted to a small percentage of his overall fortune, especially after reaching a deal with the S.E.C. (Mr. Rattner's net worth, according to a financial disclosure report filed this year, was $ 160 million to $ 500 million.)

Not exact matches

Zulilly is also profitable, reporting in its October S1 Securities and Exchange Commission filing net income of $ 2.4 million for the first six months of 2013, compared to a net loss of $ 4 million for the same six months a year earlier.

Since her father won last year's presidential election, the First Daughter's company has filed trademark requests with U.S. officials for branded lingerie, lounge wear and athletic apparel, Bloomberg reported this week.

Yet, according to financial reports filed with the Securities and Exchange Commission, that same year Trump received $ 583,333 in compensation from the then - named Trump Hotels & Casino Resorts, the company Trump had taken public in the middle of that year.

Information regarding the officers and directors of McDermott is included in its annual report on Form 10 - K for the year ended December 31, 2017, filed with the SEC on February 21, 2018, as amended by its annual report on Form 10 - K / A filed with the SEC on March 8, 2018.

It will automatically carry out benefits deductions, pay and file all of your payroll taxes, handle year - end reporting and time - tracking, ensure your small business is compliant with regulations, and give employees access to their paycheck histories.

Learn about critical 2011 W - 2 & 1099 regulatory and filing information that you should keep in mind while preparing for this tax season and year - end reporting.

The war secretary kept one print to himself, however — «He did not have the heart to destroy it,» Life magazine reported — and buried it so deep in his files that it was lost to history for almost 90 years.

Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

In its 2011 filing, which covers the last seven months of the year, Crossroads GPS reported spending almost $ 22.4 million, including $ 1.7 million on political ads, including this anti-Obama ad.

The company refers you to the documents filed by the company from time to time with the SEC, specifically the section titled «Risk Factors» in the company's Annual Report on Form 10 - K for the year ended December 31, 2017, as may be updated or supplemented in the company's Quarterly Reports on Form 10 - Q and the company's other filings with the SEC, which discuss these and other factors that could adversely affect the company's results.

In 2015, New York - based competitor Bounce Exchange filed a suit against Yieldify in a New York federal court, accusing it of copying its code and infringing its patents, in a case that first came to light earlier this year in a report from The Financial Times.

In November the five - year - old company confidentially filed to go public, according to reports, defying conventional wisdom among highly valued startups.

In a regulatory filing on Wednesday, SolarCity said it had 12,243 employees at the end of 2016, down 19.8 % from the 15,273 it reported a year earlier.

Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.

A five - year - old lawsuit against the Ivy League school, filed by its neighbors, is challenging its tax - exempt status, Bloomberg reports.

Apple has filed a $ 1 billion lawsuit against Qualcomm, claiming that for many years, the chip manufacturer has «unfairly insisted on charging royalties for technologies they have nothing to do with,» CNBC reports.

This list — called a Tier II filing — is released every year to local, state and federal officials, and includes what they imagine could occur in a «worst - case» scenario, NBC News reported.

The company was said be aiming to file an IPO registration statement by year end so it could go public in 2017, The Information reported last month.

However, The Information reports that Snapchat is looking to file either by the end of this year or early next year, so we could expect a public offering sometime in 2017.

The filing remains on a credit report for seven to 10 years, although the impact decreases over time and your score will tick upward.

There was a report last week that it was planning to file for the IPO at the end of the year, and get listed at the start of next year.

The $ 928 million center was slated to start construction late last year at a 500 - acre site in the Derrydonnell Forest near a small town called Athenry, but groundbreaking was delayed after complaints about the building were filed to the local council, reported Business Insider.

It reports $ 110 million of net income on $ 3 billion in revenue for the nine months ending Nov. 2, 2013, compared to $ 95 million in net income on $ 2.88 billion in revenue for the year - earlier period. www.michaels.com National Mentor Holdings, a Boston - based provider of home and community - based health services to children and adults with disabilities, is preparing to file for an IPO that could value the company at more than $ 1 billion, according to the Wall Street Journal.

This comes on the heels of a recent report that the company is expected by many to file an S - 1 form to go public by the end of the year and debut in early 2014.

Gilead directs readers to its press releases, Annual Report on Form 10 - K for the year ended December 31, 2017 and other subsequent disclosure documents filed with the SEC.

(Cloud storage provider Box, in its IPO filing from late last year, reported spending more than its full - year revenue for 2014 on sales and marketing.)

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Each year, the partnership files a return, Form 1065, to report to the IRS the income, gains, losses, deductions, and credits from the business, Weltman says.

Crain's New York Business has reported that a «senior» private equity insider filed a compliant with the Securities and Exchange Commission earlier this year about the so - called transaction fees that PE firms often charge when they buy a company.

According to the company's filing, SoulCycle earned $ 112 million in revenue last year, and tripled in size from 12 studios in 2012 to 36 in 2014, Business Insider reported in July.

From the published list, we selected the first 75 rank - ordered firms that had an EEO - 1 on file for 2014, which is the latest year available for EEO1 data at the time of this report.

Since he didn't file Form T2091 (the form used to designate a property as your principal residence) and report the sale on his tax return, the CRA deems him to have designated the city home as his principal residence for all the years he owned it, with the result being that no tax was owed.

Though the company has suffered some setbacks (Buffets, Inc. filed for bankruptcy in 2008 and 2012), it is currently reporting its strongest sales numbers in seven years.

Factors that could cause or contribute to actual results differing from our forward - looking statements include risks relating to: failure of DBRS to rate the Notes at the anticipated ratings levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing risks; and other risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.

Important factors that could cause actual results to differ from OnDeck's forward - looking statements are the risks that OnDeck may not be able to manage its anticipated or actual growth effectively, that its credit models do not adequately identify potential risks, and other risks, including those under the heading «Risk Factors» in OnDeck's Annual Report on Form 10 - K for the year ended December 31, 2016, its Quarterly Reports for the quarters ended June 30 and September 30, 2017 and in other documents that OnDeck files with the Securities and Exchange Commission, or SEC, from time to time which are available on the SEC website at www.sec.gov.

A 2015 bond prospectus, which HNA filed in Singapore, described it as a «related party» while annual reports filed by Hainan Airlines over 18 years stated that Pacific American was a major supplier.

The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10 - K for the year ended December 31, 2017, filed with the SEC on February 23, 2018.

Alongside many of its industry rivals, Goldman Sachs has filed its annual report with the SEC for fiscal year 2017.

The company posted a net loss of Rs 5,768.8 crore for the year through March 2016, up 86 % from a year earlier, tech news website Factor Daily reported, citing the e-tailer's annual report filed with Singapore authorities.

Also adding to the awkward questions for Facebook: Board member, Thiel, who supported Trump's presidential bid, made a $ 1M financial donation to a Trump - supporting Super PAC, called Make America Number 1, in 2016 — which Mashable reports subsequently paid Cambridge Analytica $ 231,352 toward the end of the same year, per an FEC filing.

So we won't know the real story behind the provincial decision on Kinder Morgan until April next year, when the parties file donation reports with Elections BC.

«This year once again breaks the previous record for the number of resolutions filed, and companies are having less success than ever in knocking out proposals under SEC rules,» says Andrew Behar, CEO of As You Sow, in the preface to the report.

We caution you that these statements are not guarantees of future performance and are subject to numerous risks and uncertainties, including volatility in the economy and the credit markets, supply and demand changes for vacation ownership and residential products, competitive conditions; the availability of capital to finance growth, and other matters referred to under the heading «Risk Factors» contained in our Annual Report on 10 - K for the year ended December 30, 2011 filed with the U.S. Securities and Exchange Commission (the «SEC») and in subsequent SEC filings, any of which could cause actual results to differ materially from those expressed in or implied in this presentation.

Shareholders had filed 433 resolutions related to ESG issues by the middle of February, compared with 417 in the same period last year, As You Sow says in its annual Proxy Preview report.

The decree also notes that it will terminate 20 years from the date of being issued, but that it will renew for another 20 years each time that the FTC files a complaint over any violations — meaning, if the FTC does file a complaint and is successful in determining the violation, it will prolong Facebook's own need to report and make clear privacy policies to its users.

Mathrani would receive $ 42.1 million in restricted stock and equity through GGP's incentive plan when the deal closes, and $ 7.1 million in cash if he's terminated within the next two years, according to a filing with the Securities & Exchange Commission reported by Crain's.

As described in the company's Form 8 - K filed today, the company has identified misstatements to date that would reduce previously reported fiscal year 2014 revenue by approximately $ 58 million, net income attributable to Valeant by approximately $ 33 million, and basic and diluted earnings per share by $.09.

When I filed for taxes this year that $ 45K which was not net because I took $ 10K in losses but you know how the IRS does it... I had to report $ 45K as total income and could only write off $ 3K.